1. Home
  2. TAK vs MCHP Comparison

TAK vs MCHP Comparison

Compare TAK & MCHP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • MCHP
  • Stock Information
  • Founded
  • TAK 1781
  • MCHP 1989
  • Country
  • TAK Japan
  • MCHP United States
  • Employees
  • TAK N/A
  • MCHP N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • MCHP Semiconductors
  • Sector
  • TAK Health Care
  • MCHP Technology
  • Exchange
  • TAK Nasdaq
  • MCHP Nasdaq
  • Market Cap
  • TAK 43.9B
  • MCHP 47.2B
  • IPO Year
  • TAK N/A
  • MCHP 1993
  • Fundamental
  • Price
  • TAK $13.63
  • MCHP $62.86
  • Analyst Decision
  • TAK
  • MCHP Buy
  • Analyst Count
  • TAK 0
  • MCHP 19
  • Target Price
  • TAK N/A
  • MCHP $93.05
  • AVG Volume (30 Days)
  • TAK 1.3M
  • MCHP 6.3M
  • Earning Date
  • TAK 10-31-2024
  • MCHP 11-05-2024
  • Dividend Yield
  • TAK 4.65%
  • MCHP 2.89%
  • EPS Growth
  • TAK 49.73
  • MCHP N/A
  • EPS
  • TAK 1.27
  • MCHP 1.44
  • Revenue
  • TAK $31,732,209,416.00
  • MCHP $5,496,600,000.00
  • Revenue This Year
  • TAK $4.41
  • MCHP N/A
  • Revenue Next Year
  • TAK $1.09
  • MCHP $19.86
  • P/E Ratio
  • TAK $21.56
  • MCHP $43.76
  • Revenue Growth
  • TAK 9.43
  • MCHP N/A
  • 52 Week Low
  • TAK $12.58
  • MCHP $62.63
  • 52 Week High
  • TAK $15.08
  • MCHP $100.57
  • Technical
  • Relative Strength Index (RSI)
  • TAK 39.22
  • MCHP 23.41
  • Support Level
  • TAK $13.46
  • MCHP $72.26
  • Resistance Level
  • TAK $13.75
  • MCHP $67.49
  • Average True Range (ATR)
  • TAK 0.16
  • MCHP 2.52
  • MACD
  • TAK -0.01
  • MCHP -1.16
  • Stochastic Oscillator
  • TAK 21.15
  • MCHP 1.40

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About MCHP Microchip Technology Incorporated

Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

Share on Social Networks: